These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

128 related articles for article (PubMed ID: 2537711)

  • 1. The importance of cytomegalovirus in heart-lung transplant recipients.
    Hutter JA; Scott J; Wreghitt T; Higenbottam T; Wallwork J
    Chest; 1989 Mar; 95(3):627-31. PubMed ID: 2537711
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Cytomegalovirus infections in heart and heart-lung transplant recipients.
    Wreghitt T
    J Antimicrob Chemother; 1989 Jun; 23 Suppl E():49-60. PubMed ID: 2550412
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Cytomegalovirus infections in heart and heart and lung transplant recipients.
    Wreghitt TG; Hakim M; Gray JJ; Kucia S; Wallwork J; English TA
    J Clin Pathol; 1988 Jun; 41(6):660-7. PubMed ID: 2838530
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Should heart-lung transplant donors and recipients be matched according to cytomegalovirus serologic status?
    Novick RJ; Menkis AH; McKenzie FN; Reid KR; Ahmad D
    J Heart Transplant; 1990; 9(6):699-706. PubMed ID: 2177496
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Management of cytomegalovirus antibody negative patients undergoing heart transplantation.
    Freeman R; Gould FK; McMaster A
    J Clin Pathol; 1990 May; 43(5):373-6. PubMed ID: 2164531
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Cytomegalovirus infection and survival in lung transplant recipients.
    Duncan AJ; Dummer JS; Paradis IL; Dauber JH; Yousem SA; Zenati MA; Kormos RL; Griffith BP
    J Heart Lung Transplant; 1991; 10(5 Pt 1):638-44; discussion 645-6. PubMed ID: 1659899
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Impact of cytomegalovirus hyperimmune globulin on outcome after cardiothoracic transplantation: a comparative study of combined prophylaxis with CMV hyperimmune globulin plus ganciclovir versus ganciclovir alone.
    Valantine HA; Luikart H; Doyle R; Theodore J; Hunt S; Oyer P; Robbins R; Berry G; Reitz B
    Transplantation; 2001 Nov; 72(10):1647-52. PubMed ID: 11726825
    [TBL] [Abstract][Full Text] [Related]  

  • 8. DHPG effectively treats CMV infection in heart and heart-lung transplant patients: a preliminary report.
    Icenogle TB; Peterson E; Ray G; Minnich L; Copeland JG
    J Heart Transplant; 1987; 6(4):199-203. PubMed ID: 2822880
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Cytomegalovirus disease among donor-positive/recipient-negative lung transplant recipients in the era of valganciclovir prophylaxis.
    Mitsani D; Nguyen MH; Kwak EJ; Silveira FP; Vadnerkar A; Pilewski J; Crespo M; Toyoda Y; Bermudez C; Clancy CJ
    J Heart Lung Transplant; 2010 Sep; 29(9):1014-20. PubMed ID: 20598582
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Ganciclovir treatment of serious cytomegalovirus infection in heart and heart-lung transplant recipients.
    Keay S; Petersen E; Icenogle T; Zeluff BJ; Samo T; Busch D; Newman CL; Buhles WC; Merigan TC
    Rev Infect Dis; 1988; 10 Suppl 3():S563-72. PubMed ID: 2847294
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Cytomegalovirus infections in renal, heart, heart-lung and liver transplantation.
    Pollard RB
    Pediatr Infect Dis J; 1988 May; 7(5 Suppl):S97-102. PubMed ID: 2456512
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Cytomegalovirus viremia in lung transplant recipients receiving ganciclovir and immune globulin.
    Gutiérrez CA; Chaparro C; Krajden M; Winton T; Kesten S
    Chest; 1998 Apr; 113(4):924-32. PubMed ID: 9554627
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Cytomegalovirus infection in isolated lung transplantations.
    Maurer JR; Tullis DE; Scavuzzo M; Patterson GA
    J Heart Lung Transplant; 1991; 10(5 Pt 1):647-9. PubMed ID: 1659900
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Delay of CMV infection in high-risk CMV mismatch lung transplant recipients due to prophylaxis with oral ganciclovir.
    Palmer SM; Grinnan DC; Diane Reams B; Steele MP; Messier RH; Duane Davis R
    Clin Transplant; 2004 Apr; 18(2):179-85. PubMed ID: 15016133
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Impact of cytomegalovirus match on survival after cardiac and lung transplantation.
    Bonatti H; Tabarelli W; Ruttmann E; Kafka R; Larcher C; Höfer D; Klaus A; Laufer G; Geltner C; Margreiter R; Müller L; Antretter H
    Am Surg; 2004 Aug; 70(8):710-4. PubMed ID: 15328806
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Cytomegalovirus infection in lung transplantation; current status, detection, prophylactic treatment].
    Aoe M; Tao H; Yamane M; Toyooka S; Sano Y; Okazaki M; Date H
    Kyobu Geka; 2007 Oct; 60(11):988-92. PubMed ID: 17926902
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Morbidity of cytomegalovirus infection in recipients of heart or heart-lung transplants who received cyclosporine.
    Dummer JS; White LT; Ho M; Griffith BP; Hardesty RL; Bahnson HT
    J Infect Dis; 1985 Dec; 152(6):1182-91. PubMed ID: 2999255
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Gastrointestinal cytomegalovirus infection in heart and heart-lung transplant recipients.
    Kaplan CS; Petersen EA; Icenogle TB; Copeland JG; Villar HV; Sampliner R; Minnich L; Ray CG
    Arch Intern Med; 1989 Sep; 149(9):2095-100. PubMed ID: 2549896
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Neutralizing antibody responses to reinfecting strains of cytomegalovirus in transplant recipients.
    Chou SW
    J Infect Dis; 1989 Jul; 160(1):16-21. PubMed ID: 2543709
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Active CMV infection before lung transplantation: risk factors and clinical implications.
    Milstone AP; Brumble LM; Loyd JE; Ely EW; Roberts JR; Pierson RN; Dummer JS
    J Heart Lung Transplant; 2000 Aug; 19(8):744-50. PubMed ID: 10967267
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.